» Articles » PMID: 232753

Cirrhosis of the Liver: a Reversible Disease?

Overview
Journal Pathol Annu
Specialty Pathology
Date 1979 Jan 1
PMID 232753
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

This paper is a speculative review of the irreversibility of cirrhosis of the liver. Experimental studies dealing with the specific issue of irreversibility of the process are summarized, and the following three general propositions are derived: 1. All experimental models of cirrhosis are reversible, provided the inciting agent is removed and sufficient time is allowed for the return to normal liver structure. 2. Experimental cirrhosis of the liver goes through two successive stages, differing (among many other features) in the time and completeness of their reversibility. 3. Increased reticulum fibers are more easily and completely resorbed than thick collagenous bundles. Human cases of cirrhosis of the liver in which the fact of regression appears to be sufficiently documented are also summarized. Most of them seem to fulfil the three conditions derived from the analysis of experimental data, namely, withdrawal of the etiologic agent at an early stage in their development (with a predominance of reticulum over collagen fibers) and allowance of sufficient time to document the disappearance of the disease. Experimental studies on the mechanisms of collagen degradation in general, and in the liver of mammals in particular, are also reviewed. It is concluded that much remains to be done but that the outcome is by no means hopeless.

Citing Articles

Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments.

Chen S, Zhou J, Wu X, Meng T, Wang B, Liu H Hepatol Int. 2024; 18(3):904-916.

PMID: 38565833 DOI: 10.1007/s12072-024-10643-z.


Digital pathology and spatial omics in steatohepatitis: Clinical applications and discovery potentials.

Meroueh C, Warasnhe K, Tizhoosh H, Shah V, Ibrahim S Hepatology. 2024; .

PMID: 38517078 PMC: 11669472. DOI: 10.1097/HEP.0000000000000866.


A review of liver fibrosis and cirrhosis regression.

Lee M J Pathol Transl Med. 2023; 57(4):189-195.

PMID: 37461143 PMC: 10369136. DOI: 10.4132/jptm.2023.05.24.


Molecular mechanism and research progress on pharmacology of ferulic acid in liver diseases.

Shi Y, Shi L, Liu Q, Wang W, Liu Y Front Pharmacol. 2023; 14:1207999.

PMID: 37324465 PMC: 10264600. DOI: 10.3389/fphar.2023.1207999.


The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone.

Haep N, Florentino R, Squires J, Bell A, Soto-Gutierrez A Semin Liver Dis. 2021; 41(2):213-224.

PMID: 33992030 PMC: 8996333. DOI: 10.1055/s-0041-1725023.